United Therapeutics Corporation - (UTHR) share price
United Therapeutics Corporation - (NASDAQ:UTHR) last traded at $562.02, down 0.65% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $23.94B and a 52-week range of $445.81 to $614.23.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $562.02 |
| 1-day move | -0.65% |
| 52-week range | $445.81 - $614.23 |
| Market cap | $23.94B |
| From 52-week high | -8.50% |
| Volume vs average | 0.7x |
| Falling Shares risk score | 5/100 (LOW) |
| Country | United States |
Frequently asked questions
Why is United Therapeutics Corporation - falling today?
United Therapeutics Corporation - (NASDAQ:UTHR) is down 0.65% at its latest quote and trades 8.5% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the United Therapeutics Corporation - share price today?
United Therapeutics Corporation - (NASDAQ:UTHR) last traded at $562.02, a -0.65% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of United Therapeutics Corporation -?
United Therapeutics Corporation -'s 52-week low is $445.81 and its 52-week high is $614.23; the shares trade 8.5% below the high.
What is the market cap of United Therapeutics Corporation -?
United Therapeutics Corporation - has a market capitalisation of about $23.94B at the latest price.
What are the risks of investing in United Therapeutics Corporation -?
Falling Shares Intelligence rates United Therapeutics Corporation - 5/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com